Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Raphael Pharmaceutical Inc. (RAPH) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-1.52M |
|
-- |
|
-- |
|
$1.51M |
|
$-1.51M |
|
$-0.01M |
|
$-1.52M |
|
$-1.52M |
|
$-1.52M |
|
$-1.52M |
|
$-1.52M |
|
$-1.52M |
|
$-1.51M |
|
$-1.51M |
|
18.67M |
|
18.67M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$0.03M |
|
$0.00M |
|
$0.00M |
|
$0.03M |
|
$0.77M |
|
-- |
|
-- |
|
$0.77M |
|
$-0.74M |
|
$-0.74M |
|
$-0.74M |
|
18.70M |
|
| Cash Flow Statement Financials | |
$-0.53M |
|
-- |
|
$0.32M |
|
$0.23M |
|
$0.02M |
|
$-0.21M |
|
$0.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.03 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-0.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.53M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
204.72% |
|
204.72% |
|
-5625.93% |
|
204.72% |
|
$-0.04 |
|
$-0.03 |
|
$-0.03 |
|